• Bio Green Med Solution’s third-quarter net loss narrowed 55% year over year to $449,000.
• Revenue rose to $454,000, while general and administrative expenses fell 37% year over year to $635,000.
• Cash totaled $3.45 million at September 30, 2026; management expects current resources to fund planned expenditure into the second quarter of 2027.
• A November 2026 special meeting is planned to seek shareholder approval for the proposed business combination with Future NRG.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Green Med Solution Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611121615PRIMZONEFULLFEED9875191) on November 12, 2026, and is solely responsible for the information contained therein.